I’m a Senior Biostatistician at Boehringer Ingelheim with experience across multiple sectors, united by a deep passion for healthcare innovation. Over the years, I’ve contributed to both human pharmaceutical and animal health domains, bringing statistical rigor and strategic insight to diverse projects.
Currently, I’m leading a major initiative to transition our Global Statistical Environment (GSE) from SAS to R, embracing open-source solutions to enhance flexibility, collaboration, and long-term sustainability. At BioTechX Europe, I’m keen to explore potential partnerships, tools, and best practices that can support a smooth and scalable transition.